Zhao B H, Huang Z H, Huang Y C, Zhang X W, An C M, Niu L J, Li Z J
Department of Head and Neck Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100021, China.
Zhonghua Zhong Liu Za Zhi. 2021 Apr 23;43(4):484-489. doi: 10.3760/cma.j.cn112152-20201015-00901.
To explore the applied value of super-selective cervical lymph node dissection in papillary thyroid carcinoma (PTC) patients with clinically suspicious lateral lymph node metastasis (LNM). We retrospectively analyzed the clinical data of 232 cN1b PTC patients who underwent surgery from September 2013 to May 2018 in the Department of Head and Neck Surgical Oncology, National Cancer Center. Among them, 90 cases received super-selective neck dissection (level Ⅲ and IV) and 142 cases underwent selective neck dissection (level Ⅱ-Ⅳ). The LNM of two groups were analyzed. Postoperative pathological results showed that 173 cases had LNM in the central compartment. The LNM cases of level Ⅱ-Ⅳ were 47, 147 and 130, respectively. Eight patients of super-selective neck dissection and 6 of selective neck dissection had postoperative lymphatic fistulas (=0.146). No patients in super-selective neck dissection group while 9 patients in the selective lymph node dissection group had postoperatively permanent impairment of shoulder mobility, the difference was statistically significant (=0.015). In the super-selective neck dissection group, 2 patients had long-term postoperative incision discomfort, and 5 cases had obvious cicatrix after surgery. In the patients with selective neck dissection, 27 cases experienced long-term incision discomfort after surgery, and 26 patients had apparent scar tissue, the differences were statistically significant (<0.005). There was no recurrence during the follow-up. Super-selective neck dissection is a feasible, safe and effective treatment for cN1b PTC patients. It can improve the quality of postoperative life and avoid the over treatment for patients.
探讨超选择性颈淋巴结清扫术在临床怀疑有侧方淋巴结转移(LNM)的甲状腺乳头状癌(PTC)患者中的应用价值。我们回顾性分析了2013年9月至2018年5月在国家癌症中心头颈外科肿瘤学部门接受手术的232例cN1b PTC患者的临床资料。其中,90例接受了超选择性颈部清扫术(Ⅲ和Ⅳ区),142例接受了选择性颈部清扫术(Ⅱ-Ⅳ区)。分析两组的LNM情况。术后病理结果显示,173例中央区有LNM。Ⅱ-Ⅳ区的LNM病例分别为47例、147例和130例。超选择性颈部清扫术组8例和选择性颈部清扫术组6例术后发生淋巴瘘(=0.146)。超选择性颈部清扫术组无患者术后出现肩部活动永久性障碍,而选择性淋巴结清扫术组有9例,差异有统计学意义(=0.015)。超选择性颈部清扫术组有2例患者术后长期切口不适,5例术后有明显瘢痕。选择性颈部清扫术患者中,27例术后长期切口不适,26例有明显瘢痕组织,差异有统计学意义(<0.005)。随访期间无复发。超选择性颈部清扫术对cN1b PTC患者是一种可行且安全有效的治疗方法。它可以提高患者术后生活质量,避免过度治疗。